These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 22007671

  • 21. Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain.
    Shannon AE, Chappell KJ, Stoermer MJ, Chow SY, Kok WM, Fairlie DP, Young PR.
    Protein Expr Purif; 2016 Mar; 119():124-9. PubMed ID: 26647367
    [Abstract] [Full Text] [Related]

  • 22. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.
    Zhou GC, Weng Z, Shao X, Liu F, Nie X, Liu J, Wang D, Wang C, Guo K.
    Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6549-54. PubMed ID: 24268549
    [Abstract] [Full Text] [Related]

  • 23. Allosteric inhibition of the NS2B-NS3 protease from dengue virus.
    Yildiz M, Ghosh S, Bell JA, Sherman W, Hardy JA.
    ACS Chem Biol; 2013 Dec 20; 8(12):2744-52. PubMed ID: 24164286
    [Abstract] [Full Text] [Related]

  • 24. Inhibitor Bound Dengue NS2B-NS3pro Reveals Multiple Dynamic Binding Modes.
    Gibbs AC, Steele R, Liu G, Tounge BA, Montelione GT.
    Biochemistry; 2018 Mar 13; 57(10):1591-1602. PubMed ID: 29447443
    [Abstract] [Full Text] [Related]

  • 25. Rational discovery of dengue type 2 non-competitive inhibitors.
    Heh CH, Othman R, Buckle MJ, Sharifuddin Y, Yusof R, Rahman NA.
    Chem Biol Drug Des; 2013 Jul 13; 82(1):1-11. PubMed ID: 23421589
    [Abstract] [Full Text] [Related]

  • 26. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U, Tomlinson SM, Fonner JM, Mock SA, Watowich SJ.
    J Chem Inf Model; 2014 Oct 27; 54(10):2816-25. PubMed ID: 25263519
    [Abstract] [Full Text] [Related]

  • 27. Co-refolding of a functional complex of Dengue NS3 protease and NS2B co-factor domain and backbone resonance assignment by solution NMR.
    Woestenenk E, Agback P, Unnerståle S, Henderson I, Agback T.
    Protein Expr Purif; 2017 Dec 27; 140():16-27. PubMed ID: 28751017
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
    Chanprapaph S, Saparpakorn P, Sangma C, Niyomrattanakit P, Hannongbua S, Angsuthanasombat C, Katzenmeier G.
    Biochem Biophys Res Commun; 2005 May 20; 330(4):1237-46. PubMed ID: 15823576
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Solution conformations of Zika NS2B-NS3pro and its inhibition by natural products from edible plants.
    Roy A, Lim L, Srivastava S, Lu Y, Song J.
    PLoS One; 2017 May 20; 12(7):e0180632. PubMed ID: 28700665
    [Abstract] [Full Text] [Related]

  • 34. Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
    Stoermer MJ, Chappell KJ, Liebscher S, Jensen CM, Gan CH, Gupta PK, Xu WJ, Young PR, Fairlie DP.
    J Med Chem; 2008 Sep 25; 51(18):5714-21. PubMed ID: 18729351
    [Abstract] [Full Text] [Related]

  • 35. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
    McCoy MA, Senior MM, Gesell JJ, Ramanathan L, Wyss DF.
    J Mol Biol; 2001 Feb 02; 305(5):1099-110. PubMed ID: 11162117
    [Abstract] [Full Text] [Related]

  • 36. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
    Rut W, Groborz K, Zhang L, Modrzycka S, Poreba M, Hilgenfeld R, Drag M.
    Antiviral Res; 2020 Mar 02; 175():104731. PubMed ID: 32014497
    [Abstract] [Full Text] [Related]

  • 37. Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.
    Schüller A, Yin Z, Brian Chia CS, Doan DN, Kim HK, Shang L, Loh TP, Hill J, Vasudevan SG.
    Antiviral Res; 2011 Oct 02; 92(1):96-101. PubMed ID: 21763725
    [Abstract] [Full Text] [Related]

  • 38. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
    Lai H, Teramoto T, Padmanabhan R.
    Methods Mol Biol; 2014 Oct 02; 1138():345-60. PubMed ID: 24696347
    [Abstract] [Full Text] [Related]

  • 39. Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity.
    Doan DN, Li KQ, Basavannacharya C, Vasudevan SG, Madhusudhan MS.
    Protein Eng Des Sel; 2012 Dec 02; 25(12):843-50. PubMed ID: 22972763
    [Abstract] [Full Text] [Related]

  • 40. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease.
    Schöne T, Grimm LL, Sakai N, Zhang L, Hilgenfeld R, Peters T.
    Antiviral Res; 2017 Oct 02; 146():174-183. PubMed ID: 28927677
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.